Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishen Yiqi Dripping Pills for INOCA
ChiCTR2500096748Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Feb 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of qishen yiqi dripping pills in hypoperfusion and coronary arteriosclerosis (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Myocardial flow reserve. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
qishen yiqi dripping pills
03
Conditions
hypoperfusioncoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2500096748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096748.